Tower Semiconductor Ltd. (TLV:TSEM)

Verve Therapeutics Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	17,062	20,880	12,104	16,601	13,356	8,927
Market Cap Growth	8.42%	72.51%	-27.09%	24.30%	49.62%	0.69%
Enterprise Value	13,582	17,195	8,495	14,358	12,111	7,677
Last Close Price	158.80	188.90	110.90	153.40	123.50	83.37
PE Ratio	22.53	27.58	6.48	17.85	28.63	33.74
PS Ratio	3.12	3.99	2.36	2.81	2.85	2.19
PB Ratio	1.70	2.17	1.39	2.50	2.66	1.91
P/TBV Ratio	1.70	2.17	1.39	2.52	2.68	1.93
P/FCF Ratio	-	457.55	14.48	28.89	39.95	-
P/OCF Ratio	10.59	12.78	4.97	8.91	10.19	10.04
EV/Sales Ratio	2.71	3.29	1.66	2.43	2.58	1.89
EV/EBITDA Ratio	8.47	10.46	5.14	6.87	8.91	7.20
EV/EBIT Ratio	21.62	25.51	11.72	13.52	23.39	26.23
EV/FCF Ratio	-214.82	376.80	10.16	24.99	36.23	-
Debt / Equity Ratio	0.06	0.07	0.10	0.14	0.20	0.27
Debt / EBITDA Ratio	0.35	0.40	0.50	0.45	0.71	1.15
Debt / FCF Ratio	-	14.43	1.00	1.67	2.93	-
Asset Turnover	0.48	0.48	0.52	0.70	0.70	0.63
Inventory Turnover	3.92	3.98	3.66	4.51	5.44	5.28
Quick Ratio	5.62	5.12	5.11	3.06	3.35	3.29
Current Ratio	6.93	6.18	6.17	3.86	4.33	4.04
Return on Equity (ROE)	7.90%	8.18%	24.08%	15.21%	10.04%	5.95%
Return on Assets (ROA)	3.78%	3.86%	4.60%	7.90%	4.81%	2.83%
Return on Capital (ROIC)	4.15%	4.22%	5.22%	9.23%	5.51%	3.25%
Return on Capital Employed (ROCE)	6.40%	6.60%	7.60%	14.00%	8.50%	5.00%
Earnings Yield	4.44%	3.63%	15.43%	5.60%	3.49%	2.96%
FCF Yield	-0.37%	0.22%	6.91%	3.46%	2.50%	-1.34%
Buyback Yield / Dilution	-1.23%	-1.01%	-0.42%	-0.87%	-1.21%	-0.97%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.